Works matching DE "IMIPENEM"
Results: 765
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study (2022–23)
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 583, doi. 10.1093/jac/dkae450
- By:
- Publication type:
- Article
The Efficacy of Imipenem Conjugated with Synthesized Silver Nanoparticles Against Acinetobacter baumannii Clinical Isolates, Iran.
- Published in:
- Biological Trace Element Research, 2020, v. 197, n. 1, p. 330, doi. 10.1007/s12011-019-01962-6
- By:
- Publication type:
- Article
Biosynthesis of mercapturic acid derivative of the labdane-type diterpene, cyslabdan that potentiates imipenem activity against methicillin-resistant Staphylococcus aureus: cyslabdan is generated by mycothiol-mediated xenobiotic detoxification.
- Published in:
- Journal of Industrial Microbiology & Biotechnology, 2016, v. 43, n. 2/3, p. 325, doi. 10.1007/s10295-015-1694-6
- By:
- Publication type:
- Article
Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 4, p. 2150, doi. 10.3906/sag-1910-166
- By:
- Publication type:
- Article
Effect of subinhibitory antibiotics concentrations on biofilm formation by clinical Acinetobacter baumannii isolated from endotracheal tubes in ventilator-associated pneumonia.
- Published in:
- South Asian Journal of Experimental Biology, 2021, v. 11, n. 3, p. 242, doi. 10.38150/sajeb.11(3).p242-248
- By:
- Publication type:
- Article
三种常用碳青霉烯类抗菌药物治疗急性胆道感染的疗效、安全性及药物经济学比较
- Published in:
- Pharmaceutial Care & Research, 2022, v. 22, n. 1, p. 39, doi. 10.5428/pcar20220108
- By:
- Publication type:
- Article
我院2015-2018 年度抗菌药物的使用强度与鲍曼不动杆菌的 耐药性的关系研究.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 8, p. 1513, doi. 10.13241/j.cnki.pmb.2020.08.024
- By:
- Publication type:
- Article
Salmonella serovars associated with Grenadian tree boa (Corallus grenadensis) and their antimicrobial susceptibility.
- Published in:
- Veterinary Medicine & Science, 2020, v. 6, n. 3, p. 565, doi. 10.1002/vms3.234
- By:
- Publication type:
- Article
Prevalence and phenotypic pattern of antibiotic resistance of Acinetobacter baumannii isolated from different types of raw meat samples in Isfahan, Iran.
- Published in:
- Veterinary Medicine & Science, 2020, v. 6, n. 1, p. 147, doi. 10.1002/vms3.199
- By:
- Publication type:
- Article
Assesment of Antimicrobial Resistance Modes in Children with Pyelonephritis.
- Published in:
- Journal of Chemical Health Risks, 2022, v. 12, n. 3, p. 517, doi. 10.22034/jchr.2022.690409
- By:
- Publication type:
- Article
In-vitro activity of newly-developed β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal β-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2025, v. 44, n. 2, p. 277, doi. 10.1007/s10096-024-04965-x
- By:
- Publication type:
- Article
Emergence of a novel FRI-type carbapenemase; blaFRI-12 in Enterobacter asburiae located on an IncR plasmid.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 10, p. 2047, doi. 10.1007/s10096-024-04907-7
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy—SMART 2017–2021.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 7, p. 1343, doi. 10.1007/s10096-024-04756-4
- By:
- Publication type:
- Article
Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 9, p. 1145, doi. 10.1007/s10096-023-04647-0
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 3, p. 365, doi. 10.1007/s10096-023-04549-1
- By:
- Publication type:
- Article
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 2, p. 319, doi. 10.1007/s10096-021-04363-7
- By:
- Publication type:
- Article
In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 1, p. 63, doi. 10.1007/s10096-021-04341-z
- By:
- Publication type:
- Article
KPC-12 with a L169M substitution in the Ω loop has reduced carbapenemase activity.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 8, p. 1761, doi. 10.1007/s10096-021-04198-2
- By:
- Publication type:
- Article
Ceftazidime-avibactam, meropenen-vaborbactam, and imipenem-relebactam in combination with aztreonam against multidrug-resistant, metallo-β-lactamase-producing Klebsiella pneumoniae.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 8, p. 1755, doi. 10.1007/s10096-021-04197-3
- By:
- Publication type:
- Article
Study on risk factors, bacterial species, and drug resistance of acute pyelonephritis associated with ureteral stent after percutaneous nephrolithotomy.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 4, p. 707, doi. 10.1007/s10096-020-04050-z
- By:
- Publication type:
- Article
Is it time to move away from polymyxins?: evidence and alternatives.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 3, p. 461, doi. 10.1007/s10096-020-04053-w
- By:
- Publication type:
- Article
Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2020, v. 39, n. 6, p. 1185, doi. 10.1007/s10096-020-03844-5
- By:
- Publication type:
- Article
Breakpoint beware: reliance on historical breakpoints for Enterobacteriaceae leads to discrepancies in interpretation of susceptibility testing for carbapenems and cephalosporins and gaps in detection of carbapenem-resistant organisms.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2020, v. 39, n. 1, p. 187, doi. 10.1007/s10096-019-03711-y
- By:
- Publication type:
- Article
In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 11, p. 2045, doi. 10.1007/s10096-019-03639-3
- By:
- Publication type:
- Article
Correction to: In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 6, p. 1143, doi. 10.1007/s10096-019-03517-y
- By:
- Publication type:
- Article
Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of <italic>Acinetobacter baumannii</italic>.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 3, p. 443, doi. 10.1007/s10096-018-3189-7
- By:
- Publication type:
- Article
Comparison of MALDI-ToF MS with the Rapidec Carba NP test for the detection of carbapenemase-producing Enterobacteriaceae.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 1, p. 149, doi. 10.1007/s10096-017-3115-4
- By:
- Publication type:
- Article
Carbapenem-heteroresistance among isolates of the Enterobacter cloacae complex: is it a real concern?
- Published in:
- 2018
- By:
- Publication type:
- Letter
Evaluation of several phenotypic methods for the detection of carbapenemase-producing Pseudomonas aeruginosa.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2015, v. 34, n. 7, p. 1467, doi. 10.1007/s10096-015-2376-z
- By:
- Publication type:
- Article
Corrigendum: Formulation of phage cocktails and evaluation of their interaction with antibiotics in inhibiting carbapenemase-producing Klebsiella pneumoniae in vitro in Kenya.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Nowe opcje terapeutyczne w leczeniu zakażeń u pacjentów hospitalizowanych w OIT - komu, kiedy i dlaczego.
- Published in:
- Anaesthesiology & Rescue Medicine / Anestezjologia i Ratownictwo, 2021, v. 15, n. 1, p. 44, doi. 10.53139/AIR.20211506
- By:
- Publication type:
- Article
Antibiotic Resistance of Pseudomonas aeruginosa in Well Waters in Irrigated Zone (Middle Atlas-Morocco).
- Published in:
- Nature Environment & Pollution Technology, 2019, v. 18, n. 4, p. 1193
- By:
- Publication type:
- Article
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 4, p. 1443, doi. 10.1007/s40121-022-00607-x
- By:
- Publication type:
- Article
Molecular epidemiologic and clinical analysis of Helicobacter cinaedi bacteremia in Japan.
- Published in:
- Helicobacter, 2020, v. 25, n. 1, p. N.PAG, doi. 10.1111/hel.12675
- By:
- Publication type:
- Article
Reversible black tongue: A little known side effect of imipenem/cilastatin and evidence for novel mode of action.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 2, p. 370, doi. 10.1111/jcpt.13066
- By:
- Publication type:
- Article
Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?—Results of an in vitro study.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2018, v. 43, n. 6, p. 836, doi. 10.1111/jcpt.12722
- By:
- Publication type:
- Article
The Role of nmcR , ampR , and ampD in the Regulation of the Class A Carbapenemase NmcA in Enterobacter ludwigii.
- Published in:
- Frontiers in Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fmicb.2021.794134
- By:
- Publication type:
- Article
Undetectable Production of the VIM-1 Carbapenemase in an Atlantibacter hermannii Clinical Isolate.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.741972
- By:
- Publication type:
- Article
In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.727946
- By:
- Publication type:
- Article
Rapid Detection of Imipenem Resistance in Gram-Negative Bacteria Using Tabletop Scanning Electron Microscopy: A Preliminary Evaluation.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.658322
- By:
- Publication type:
- Article
Impact of an Intervention to Control Imipenem-Resistant Acinetobacter baumannii and Its Resistance Mechanisms: An 8-Year Survey.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2020.610109
- By:
- Publication type:
- Article
Investigation of Bacterial Isolations and Antimicrobial Susceptibility of Chronic Rhinitis in Cats.
- Published in:
- Animals (2076-2615), 2022, v. 12, n. 12, p. 1572, doi. 10.3390/ani12121572
- By:
- Publication type:
- Article
High Prevalence of Antibiotic-Resistant Escherichia coli Isolates from Retail Poultry Products in Spain.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Antibiotic therapy of diabetic foot infections: A systematic review of randomized controlled trials.
- Published in:
- Wound Repair & Regeneration, 2018, v. 26, n. 5, p. 381, doi. 10.1111/wrr.12649
- By:
- Publication type:
- Article
Reply: Comments on the Published Meta-Analysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections.
- Published in:
- Infection & Chemotherapy, 2021, v. 53, n. 3, p. 570, doi. 10.3947/ic.2021.0089
- By:
- Publication type:
- Article
Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/ Relebactam in Complicated Infections: A Meta-analysis.
- Published in:
- Infection & Chemotherapy, 2021, v. 53, n. 2, p. 271, doi. 10.3947/ic.2021.0051
- By:
- Publication type:
- Article
Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.
- Published in:
- Drugs, 2022, v. 82, n. 4, p. 407, doi. 10.1007/s40265-022-01676-5
- By:
- Publication type:
- Article
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
- Published in:
- Drugs, 2018, v. 78, n. 1, p. 65, doi. 10.1007/s40265-017-0851-9
- By:
- Publication type:
- Article